Search for: "dr. reddy's"
Results 301 - 320
of 395
Sort by Relevance
|
Sort by Date
29 Jun 2009, 5:33 pm
And there are a couple of fishing expeditions still in progress: Dr. [read post]
28 May 2009, 6:55 pm
Dr. [read post]
20 May 2009, 7:05 am
Manoj Mitta also points out that the precedent of asking the Prime Minister to seek a vote of confidence was set by Sanjiva Reddy in 1979. [read post]
20 May 2009, 5:18 am
: Dr Reddy’s post grant opposition against Pfizer’s Champix patent (Spicy IP) Tanzania generic pharma sector set for growth (Afro-IP) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs) (Patents4Life) US: Obvious-type double… [read post]
13 May 2009, 11:44 pm
Dr. [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and correction of patent term adjustment calculation in respect… [read post]
6 May 2009, 9:54 am
The post-grant opposition is filed by Dr. [read post]
4 May 2009, 5:56 pm
In the pharma sector, Dr. [read post]
13 Apr 2009, 5:00 am
Another example is Merck’s authorized generic deal with Dr. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
23 Mar 2009, 2:21 pm
Reddy's Laboratories, and Cobalt Pharmaceuticals. '639 claims an anti-epileptic drug that UCB markets as Keppra. [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma submissions relating to… [read post]
13 Mar 2009, 2:00 am
(Patent Baristas) US: Schering merger includes legal headaches for Merck, including IP suits (Law360) US: Lessig and Eisen article ‘Is John Conyers Shilling for Special Interests’ concerning proposal to ban open access publishing requirement for taxpayer funded medical scientists (Huffington Post) (Lessig) (Lenz Blog) (Lessig) (Lenz Blog) (Michigan Messenger) (Lessig) US: McCain touts drug imports to lower US costs (Law360) US: Biotech and pharma provide little support in… [read post]
12 Mar 2009, 1:15 am
Dr. [read post]
16 Feb 2009, 9:00 pm
In this week's call, regular panelists Jeremy Phillips, Shamnad Basheer and Duncan Bucknell are joined by special guests Nick Redfearn and Don Zuhn to discuss: Fallout from the World Trade Organisation dispute between China and the United States; Dr Reddy's, CIPLA, India, Brazil and the EU and the emerging controversy over seized pharmaceutical goods; TRIPS compliance and too much protection within a country; The infringement approach to goods… [read post]
13 Feb 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Cozaar (Losartan) – Brazil/India/EU: Brazilian ambassador to WTO condemns EU for seizing shipment of generic drugs bound for Brazil; Dr Reddy’s takes prudent option, asks for return of seized consignment (IP tango) (Spicy IP) (GenericsWeb) US: Senate bill would prevent reverse pharma payments –… [read post]
9 Feb 2009, 9:56 pm
By Suresh Pillai --GeoPharma and Dr. [read post]
25 Jan 2009, 7:44 pm
Reddy's on route to Brazil. [read post]
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
22 Jan 2009, 11:57 pm
Dr. [read post]
